Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Vietnam to Secure 31 Million Doses of Pfizer, BioNTech's COVID-19 Jab in 2021

05/14/2021 | 05:47am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
06/15CSTONE PHARMACEUTICALSá : Pfizer to Work Together to Develop Lung Cancer Drug in..
MT
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
MT
06/15PFIZERá : 899 people got expired vaccine doses at Times Square site
AQ
06/15INDIAN SCIENTISTS : We didn't back doubling of vaccine dosing gap
RE
06/15ASTRAZENECAá : How UK PM Johnson decided to delay COVID reopening
RE
06/15INDIAN SCIENTISTS : We didn't back doubling of vaccine dosing gap
RE
06/15GLOBAL MARKETS LIVE : General Electric, AstraZeneca, H&M, Bohoo, Implenia...
06/15Mitsubishi UFG Says Sterling's Positive Outlook Clouded by Spread of COVID-19..
MT
06/15PFIZERá : Trudeau to visit Pfizer on last day of international pandemic trip, be..
AQ
06/15WALL STREET STOCK EXCHANGE : Inflation and pricing power
More news
Financials (USD)
Sales 2021 72 305 M - -
Net income 2021 17 466 M - -
Net Debt 2021 26 268 M - -
P/E ratio 2021 13,4x
Yield 2021 3,98%
Capitalization 222 B 222 B -
EV / Sales 2021 3,43x
EV / Sales 2022 4,02x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 42,29 $
Last Close Price 39,59 $
Spread / Highest target 33,9%
Spread / Average Target 6,82%
Spread / Lowest Target -9,07%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER, INC.7.55%221 613
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582
ELI LILLY AND COMPANY32.39%203 185